反HMGCR神经病变模仿的骨头骨骨肌肉缩症
Andreas Albert Braun1,2, Monika Atiya3, Katja Göhner4
1Department of Neurology, University Hospital Zurich, Zurich, Switzerland.
Open medicine (Warsaw, Poland)
|September 9, 2024
概括
与他类药物相关的肌肉问题可以表现为免疫介导肌肉病,即使在药物停止数年后也是如此. 通过对抗-3-基-3-甲基酸辅酶A减少酶 (HMGCR) 抗体测试进行早期检测是有效治疗的关键.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 类他类药物可以导致肌肉问题,包括肌痛和狂肌病.
- 免疫媒介性菌性肌炎 (IMNM) 是一种罕见但严重的与他类药物相关的肌病.
- 诊断可能具有挑战性,特别是在异常表现的老年患者中.
研究的目的:
- 在使用他类药物后呈现晚发性免疫媒介肌肉病变的病例.
- 要突出抗HMGCR抗体的诊断效用.
- 强调在与他类药物相关的肌肉症状中考虑免疫介导肌肉病变的重要性.
主要方法:
- 一个72岁的病人的病例报告,在他类药物治疗后持续肌肉衰弱.
- 诊断工作包括肌酸激酶 (CK) 水平和抗体测试.
- 进行了肌肉活检,并监测了免疫治疗的反应.
主要成果:
- 患者呈现出近端肌肉衰弱和CK水平升高的情况.
- 检测到高水平的抗-3-基-3-甲基氨酸辅酶A减少酶 (HMGCR) 抗体.
- 肌肉活检显示没有显著的炎症变化,但患者对免疫抑制疗法反应良好.
结论:
- 抗HMGCR抗体测试对于诊断免疫介导肌肉病变至关重要,特别是在异型呈现或缺少炎症标志物的情况下.
- 在使用他类药物后,延迟发作的肌肉衰弱应促使人们考虑免疫媒介肌肉病变.
- 及时诊断和免疫疗法治疗可以导致显著的临床改善.
相关概念视频
Satellite Stem Cells and Muscular Dystrophy
1.9K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K
Myasthenia Gravis: Diagnostic Tests
699
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
699
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Disorders of the Skeletal Muscle
904
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
904


